INVESTIGATIVE
RESEARCH
DIVISION
CLASS
PUBLIC
REPORT
NO. 01
2026
Vol. 01 / 2026
USA · CALIFORNIA
Field Report 01
— Alethea Field Report 01 / Occupational Health

DUST

The Next Asbestos: How the cheapest countertop in America is killing the people who cut it.

An investigation into the engineered‑stone silicosis epidemic — the regulatory failures that produced it, the federal liability shield bill that would entrench it, and the next product already lining up to follow the same arc: luxury vinyl plank flooring.

Lead Investigator Marc A. Reynolds Editor
May 2026 · Investigation Open
Editor's Brief

This was preventable. Most of it was preventable a decade ago.

In December 2023, a 38‑year‑old countertop fabricator in the San Fernando Valley walked into an occupational medicine clinic having gone two decades without seeing a doctor. He played soccer every weekend. He was, in his own words, perfectly healthy. His physician told him that if he ignored the diagnosis he had just been given, he would likely be dead within two years. He had silicosis — a disease American medicine considered a 19th‑century occupational hazard, largely eradicated by the 1970s. He was the first of 542 confirmed cases California would record by April 2026.

The material that did this to him is sold to the public as a premium kitchen upgrade. It is marketed under brand names like Caesarstone, Silestone, Cambria, and Vicostone. It is the dominant new‑construction countertop in the United States, accounting for 28% of the residential market and growing at over 8% annually. And its fabrication — the cutting, grinding, and polishing of slabs in small shops largely staffed by Latino immigrants — releases dust that is, by mass, up to 97% crystalline silica. Granite contains 10–45%. Marble contains less than 5%. Engineered stone is, functionally, weaponized silica.

In 2024, Australia became the first country in the world to ban engineered stone outright, after determining that no combination of ventilation, wet cutting, and respiratory protection could be safely deployed across the industry. California is now formally considering the same step. A federal bill, introduced in September 2025, would shield the manufacturers from civil suits — the legal playbook previously used by the asbestos, tobacco, opioid, and firearms industries.

This report documents what is known, who is responsible, what is being done, and what should be done. It closes with a forward‑look at the next product on the same trajectory: luxury vinyl plank flooring — a PVC‑based composite now installed in roughly one of every three American kitchens and bathrooms. The structural conditions that produced the silicosis crisis are reproducing themselves around a different chemistry.

— Marc A. Reynolds, Lead Investigator · Alethea Solutions

Executive Summary · Principal Findings

What this investigation establishes.

  1. F‑01The disease is real, current, and accelerating. California confirmed silicosis cases climbed from 69 in 2022 to 542 by April 2026 — an 8× surge in three years. 29 deaths to date. Public‑health modeling projects 485–848 total cases and up to 161 deaths among California fabricators from current exposure alone.
  2. F‑02Engineered stone is the cause. The material contains up to 97% crystalline silica versus 10–45% for granite. When cut or ground, it releases respirable particles that lodge irreversibly in lung tissue. The disease this produces is progressive, incurable, and increasingly accelerated — onset in years rather than the decades typical of historical mining‑era silicosis.
  3. F‑03The victim profile is consistent. The overwhelming majority of cases involve young Latino immigrant men working in small shops — many under 35 at diagnosis, several requiring double lung transplants in their 20s and 30s simply to survive.
  4. F‑04Australia banned it. The U.S. has not. In 2024, Australia prohibited the manufacture, supply, and installation of engineered stone above 1% crystalline silica. The Australian market promptly transitioned to silica‑free alternatives with equivalent quality, look, and feel. The same alternatives exist for the U.S. market.
  5. F‑05California is now considering a ban. The Western Occupational & Environmental Medical Association petitioned Cal/OSHA in December 2025. The Standards Board is voting on whether to advance the rulemaking at its May 21, 2026 meeting. If approved, California would become the first U.S. state to ban the material outright.
  6. F‑06A federal bill would shield the manufacturers. The Protection of Lawful Commerce in Stone Slab Products Act (H.R., Rep. Tom McClintock, Sept 2025) would largely immunize manufacturers and distributors from civil suits — a legal architecture borrowed directly from the Protection of Lawful Commerce in Arms Act (firearms, 2005).
  7. F‑07The asbestos parallel is explicit. Industry publications, occupational medicine specialists, and Bloomberg Law have all framed engineered stone silicosis as "the next black lung" and "the next asbestosis." The U.S. did not finalize a federal asbestos ban until 2024 — six decades after the disease pattern became clear. The same delay is now in motion for engineered stone.
  8. F‑08Luxury Vinyl Plank may be next. LVP is PVC‑based and uses vinyl‑chloride monomer (IARC Group 1 carcinogen) in manufacture, plasticizers with documented endocrine‑disruption signals, and microplastic‑shedding wear surfaces with negligible end‑of‑life recyclability. The category is growing at 13.4% annually with virtually no installation‑worker health surveillance.
By the Numbers

The crisis, in current data.

542
Confirmed CA silicosis cases · April 2026
8×
Increase in confirmed cases since 2022
29
Deaths attributed in California to date
~97%
Silica content of engineered stone
~100K
U.S. fabrication workers potentially exposed
1 in 4
Australian fabricators diagnosed pre‑2018
161
Projected CA deaths from current cohort
2024
Australia bans engineered stone
File 01 · MaterialComposition · why this product, this disease
01

The Material

A manufactured stone that contains more silica than the lung was ever designed to encounter.

Engineered stone — sold under the brand names Caesarstone, Silestone (Cosentino), Cambria, Vicostone, MSI Q‑Quartz, HanStone, and others — is manufactured by pulverising natural quartz into a fine powder, mixing it with polymer resin to bind the particles, and pressing the resulting slurry into slabs under heat and pressure. The product is durable, non‑porous, available in consistent colors and patterns, and visually convincing as a substitute for natural stone. It is also, in raw material terms, up to 97% crystalline silica by mass.

Silica Content · Engineered85–97% crystalline silica by mass
Silica Content · Granite10–45% (variable by formation)
Silica Content · Marble< 5%
Binder System7–10% polymer resin (polyester or acrylic) + pigments
Particle Hazard ClassRespirable Crystalline Silica (RCS) · IARC Group 1 carcinogen
U.S. Market Share~28% of residential countertop installs · 2025 (Grand View Research)
Growth Rate8.2% CAGR projected 2026–2033

The high silica concentration is not incidental — it is the engineering choice that gives the product its hardness, scratch resistance, and stain performance. The polymer resin holds the silica matrix together, and the resulting slab can be cut, edged, and polished using the same diamond‑tooled equipment a fabricator would use for granite. The fabrication processes are identical. The dust produced is not.

When a fabricator cuts, grinds, or polishes an engineered‑stone slab — particularly with the high‑speed dry methods endemic to small, undercapitalised shops — the resulting dust is dominated by respirable crystalline silica particles small enough to bypass the upper airway and penetrate the deepest alveolar regions of the lung. There, recent research from the University of Turin and Adelaide has identified that the freshly‑fractured silanol groups on these particles are more biologically reactive than equivalent dust from natural stone — producing more severe inflammation and tissue scarring per unit dose.

"The severity of lung disease in workers contrasts with what we historically observed in natural‑stone trades. We are seeing accelerated disease in younger workers with shorter exposure histories." — Engineered Stone Dust Toxicity research, ACS Chemical Research in Toxicology, 2025

The material itself is not the only failure. The product was brought to market and aggressively marketed in the U.S. and Australia without industry‑wide hazard communication about the silica concentration relative to natural stone. Many fabricators interviewed for occupational‑medicine case studies report that they understood they were working with "quartz" — and assumed, reasonably, that this was equivalent in hazard to granite. It was not. They were never told.

File 02 · PathologySilicosis · accelerated form · clinical course
02

The Disease

Progressive. Incurable. Increasingly diagnosed in workers in their twenties and thirties.

Silicosis is the lung disease produced by inhalation of respirable crystalline silica. The particles deposit in the alveoli — the gas‑exchange terminals of the lung — where the immune system attempts and fails to clear them. The resulting chronic inflammation produces fibrosis: dense, irreversible scarring that progressively reduces the lung's capacity to oxygenate blood. The disease is progressive (it worsens even after exposure ends), incurable (no treatment reverses the scarring), and ultimately fatal in its advanced forms unless a lung transplant intervenes.

Disease MechanismRespirable particles <10 μm reach alveoli · trigger chronic inflammation · produce irreversible fibrosis
Classical (Chronic) Form10–30 years exposure · onset typically 50s–70s · historical mining/quarry pattern
Accelerated Form5–10 years exposure · onset 30s–40s · increasingly common pattern
Acute FormMonths to a few years · catastrophic short‑exposure cases · previously rare
Treatment OptionsSupplemental oxygen · lung transplant in advanced cases · no curative therapy
5‑Year Mortality (Advanced)High · varies by stage at diagnosis
Associated RisksTuberculosis (3× increased risk) · lung cancer · autoimmune disease · kidney disease

The pattern observed in engineered‑stone fabricators departs from the historical disease in two critical ways. First, the timeline has collapsed. Where mining‑era silicosis was a disease of late career and retirement, engineered‑stone cases are appearing in workers in their twenties, thirties, and forties — with documented exposure histories of as little as three to seven years. Second, the proportion of advanced cases at first diagnosis is substantially higher than expected from a chronic disease — because the disease is not chronic. It is acute or accelerated, racing ahead of routine surveillance.

"In three decades of litigating toxic injury cases for workers, I had never seen silicosis affect men this young. My clients were mostly men in their 60s or 70s. Then a physician referred me to a 35‑year‑old." — Raphael Metzger, toxic tort attorney, quoted in In These Times, April 2026

Several California cases now in litigation involve workers diagnosed in their late twenties who require continuous supplemental oxygen and are awaiting double lung transplants. Lung transplantation is itself a high‑risk, life‑limiting intervention — five‑year survival post‑transplant remains under 60%, and recipients face lifelong immunosuppression with its attendant cancer and infection risks. For a 28‑year‑old fabricator, the question is not whether silicosis will be the cause of death. It is when.

Clinical Note · Active Surveillance Required

The Western Occupational & Environmental Medical Association recommends chest radiography with B‑Reader classification (ILO pneumoconiosis system) and pulmonary function testing for all engineered‑stone fabrication workers, repeated at minimum every 12–24 months. Current OSHA regulations do not require reporting of B‑Reader results to public health authorities — meaning the case count almost certainly under‑represents the true incidence.

File 03 · CasualtiesDemographics · who is dying · why this population
03

The Workers

A workforce structurally selected for vulnerability — and structurally invisible to the regulatory apparatus.

The casualties of the engineered‑stone silicosis epidemic are not distributed at random across the U.S. fabrication workforce. The overwhelming majority are young, Latino, male, and immigrant — many undocumented, the majority working in small shops with five to twenty employees in regions of high housing‑market activity (San Fernando Valley, North Texas, South Florida). The Cal/OSHA case files reflect this pattern with near‑uniformity.

Median Age at Diagnosis38 years (CA registry, vs ~60+ historically)
Ethnic Composition~95% Latino · majority Mexican or Central American origin
Documentation StatusSignificant proportion undocumented · acts as barrier to medical care and workers' comp
Geographic ConcentrationSan Fernando Valley · North Texas · South Florida · Phoenix metro
Typical Shop Size5–20 employees · undercapitalized · minimal engineering controls
Healthcare AccessLow · many lack employer‑sponsored insurance · ineligible for ACA marketplace if undocumented

This demographic concentration is not coincidence. It is the predictable consequence of a labour market in which workers with fewer alternatives — fewer legal protections, less English fluency, less institutional knowledge of OSHA rights — are channelled into the work that other workers, equipped with options, decline. The same structural pattern produced the disproportionate impact of black lung on Appalachian coal communities and asbestos exposure on shipyard workers and insulation installers. The disease selects for the workforce that can least defend against it.

"He had worked for more than a decade with engineered stone. His doctor warned that, if he ignored the condition, he could be dead within a couple of years. He had not gone to the doctor in twenty years. He played soccer every weekend. He was, in his words, perfectly healthy." — Case file summary, "Hernandez" (pseudonym), In These Times, April 2026

The fact that these workers are often undocumented also has direct policy consequences. Many are reluctant to file workers' compensation claims or report unsafe conditions for fear of immigration enforcement. Several California cases progressed to advanced disease before diagnosis specifically because the worker avoided medical contact for years. Several federal lawmakers have proposed measures that would further restrict legal recourse — including the manufacturer liability shield discussed in Section 06 of this report.

The wage replacement available under California temporary total disability is currently $264.61 to $1,764.11 per week (2026 STOP Act schedule). For a worker supporting a family in Los Angeles or Houston, this is a survival income at best. For an undocumented worker who fears immigration consequences from filing, it is often not accessed at all.

File 04 · PrecedentThe asbestos analogue · timeline of disease, denial, ban
04

The Asbestos Parallel

Same playbook. Same delay. Same demographic absorbing the cost while the warning is debated.

Engineered‑stone silicosis is not the first time the United States has confronted an occupational lung disease produced by an industrial material that was, simultaneously, a desirable consumer product. Asbestos is the closest analogue — and the analogue most frequently invoked by occupational medicine specialists, plaintiff attorneys, and industry safety publications themselves.

The structural pattern is, point for point, identical:

PHASE 1
Product introduced as superior alternative. Asbestos: fireproof, durable, cheap. Engineered stone: durable, non‑porous, marble‑look at granite price.
PHASE 2
Disease pattern emerges in workers. Asbestos: shipyard workers, insulation installers, miners. Engineered stone: small‑shop fabricators, predominantly immigrant.
PHASE 3
Industry disputes causation. Asbestos: decades of manufacturer denial, internal documents later revealed as showing earlier knowledge. Engineered stone: currently in progress — manufacturers argue slabs are "not defective" and that workers misused the product.
PHASE 4
Regulatory action lags behind disease. Asbestos: U.S. did not finalize a federal ban until 2024, six decades after disease pattern was clear. Engineered stone: Australia banned 2024, U.S. still considering as of May 2026.
PHASE 5
Litigation drives partial accountability. Asbestos: hundreds of billions in settlements, multiple bankrupt manufacturers, Manville Trust. Engineered stone: litigation currently building, federal liability shield bill pending.
PHASE 6
Substitute materials emerge. Asbestos: fiberglass, mineral wool, cellulose. Engineered stone: silica‑free Caesarstone Mineral, Cambria's emerging low‑silica lines, sintered‑stone alternatives (Dekton, Neolith).
"Litigation drives change. You can see it in asbestos. You can see it in tobacco. The reason the manufacturers want a federal liability shield is that they understand exactly what's coming if they don't get one." — David Michaels, former OSHA Administrator, quoted in CBS News, March 2026

One distinction matters. Asbestos disease (mesothelioma in particular) typically presented 20–40 years after exposure — long enough that the connection between product and harm was actively contested by industry, and long enough that many of the responsible decision‑makers had retired or died by the time accountability arrived. Engineered‑stone silicosis is presenting in 3–10 years. The disease pattern, the responsible manufacturers, the responsible regulators, and the workers harmed are all currently identifiable, currently active, and currently in the same room. The delay strategy that worked for asbestos will not work the same way here. The industry knows this. The federal liability shield bill is the response.

File 05 · RegulatoryAustralia ban · California STOP Act · pending state ban
05

The Response

Australia has acted. California is moving. The federal government is not.

The Australian decision, finalised in July 2024, prohibits the manufacture, supply, and installation of any engineered stone product containing more than 1% crystalline silica. The reasoning was straightforward: Safe Work Australia conducted a formal review concluding that even with best‑available engineering controls — wet cutting, local exhaust ventilation, mandatory respiratory protection — the residual silica exposure was unacceptable. The product itself was the hazard. No combination of controls applied at small‑shop scale could eliminate it.

The Australian market did not collapse. Manufacturers pivoted to silica‑free formulations within months — Caesarstone, Cosentino, and others introduced product lines using recycled glass, porcelain composite, or low‑silica aggregates. The substitute materials carry similar aesthetic profiles. Australian consumers continued to install premium engineered‑surface countertops. The fabrication workforce stopped getting silicosis.

Australia Action2024 — Ban on engineered stone >1% crystalline silica
U.S. Federal ActionNone to date
California STOP Act (SB‑20)Signed Oct 2025 · Effective Jan 1, 2026 · Bans dry cutting, requires certification, designates silica disease as serious injury
CA Pending BanCal/OSHA Standards Board · expedited rulemaking review · May 21, 2026 vote
CA Industry ReportingConfirmed cases must be reported within 24 hours (STOP Act)
Other State ActivityNo other state has yet replicated CA's STOP Act framework

California's STOP Act represents the most aggressive U.S. state response to date. It prohibits dry cutting outright, requires shop certification, mandates that silica‑related illness be classified as a serious labour‑code injury (triggering enhanced reporting and penalty schedules), and requires 24‑hour case reporting to the California Department of Public Health and Cal/OSHA. The Western Occupational & Environmental Medical Association — representing more than 600 physicians across seven states — petitioned in December 2025 for the state to go further and adopt the Australian framework outright.

"Education and enforcement alone will not be sufficient to curtail the escalating occupational health emergency caused by engineered stone. If California follows Australia's lead, it is highly likely that safer products will be made immediately available in the California market, without significant economic consequences for fabrication businesses and their workers." — Western Occupational & Environmental Medical Association petition to Cal/OSHA, December 2025

The Cal/OSHA Standards Board is scheduled to vote on whether to advance the petition to formal rulemaking at its May 21, 2026 meeting in Los Angeles. If it does, California will become the first U.S. state to ban engineered stone. The federal government has indicated no intention of following.

Regulatory Status · Current

At the federal level, OSHA's existing silica standard (29 CFR 1910.1053) sets a permissible exposure limit of 50 µg/m³ averaged over 8 hours. Compliance is enforced through workplace inspections, which are statistically rare in small fabrication shops. As of 2026, no federal rulemaking on engineered‑stone‑specific controls is under active development.

File 06 · LiabilityH.R. liability shield · McClintock bill · September 2025
06

The Shield

A federal bill, modelled on the firearms‑industry liability shield, that would immunize manufacturers as the disease cohort matures.

In September 2025, Representative Tom McClintock (R‑CA) introduced the Protection of Lawful Commerce in Stone Slab Products Act. The bill, if enacted, would broadly shield manufacturers and distributors of engineered stone from civil lawsuits arising from the manufacture or sale of their products. Liability would be redirected away from the manufacturer and toward the individual employer alleged to have failed to follow OSHA standards.

The legal architecture is borrowed, almost verbatim, from the Protection of Lawful Commerce in Arms Act (PLCAA, 2005) — the federal liability shield enacted to protect firearms manufacturers from civil suits arising from criminal misuse of their products. PLCAA has been credited by gun‑policy researchers with substantially insulating the firearms industry from the financial accountability that drove tobacco, asbestos, and opioid reform.

BillProtection of Lawful Commerce in Stone Slab Products Act
IntroducedSeptember 2025 · House Judiciary subcommittee hearing January 2026
SponsorRep. Tom McClintock (R‑CA)
EffectLargely shields manufacturers / distributors from civil liability arising from product manufacture or sale
Liability Redirected ToIndividual employers alleged to have violated OSHA standards
Legal ModelProtection of Lawful Commerce in Arms Act (PLCAA, 2005)
StatusActive · subcommittee hearing held · floor vote pending
"In the United States, we don't ban products. The EPA only finalized its ban on asbestos in 2024, after a decades‑long fight by health and safety advocates and an annual death toll of nearly 40,000." — Raphael Metzger, toxic tort attorney, quoted in In These Times, April 2026

The political logic of the bill is straightforward. Engineered‑stone manufacturers — primarily multinational firms headquartered in Israel (Caesarstone), Spain (Cosentino's Silestone), Vietnam (Vicostone), and Minnesota (Cambria) — face an emerging legal exposure that, by the asbestos precedent, could exceed tens of billions of dollars over the coming decades. The cohort of currently‑exposed workers is large (estimated 100,000+ U.S. fabricators), the disease pattern is well‑documented, the demographic concentration of plaintiffs is favourable to class‑action litigation, and the manufacturers' marketing materials of the 2010s — which downplayed the silica differential from natural stone — will be subject to discovery. A federal liability shield, enacted before the cases mature, is the most cost‑effective insurance the industry can purchase.

Opponents of the bill — including occupational medicine specialists, plaintiff attorneys, and former OSHA Administrator David Michaels — warn that removing litigation pressure would eliminate one of the few mechanisms capable of driving product reform when regulatory action is insufficient. The historical record is clear: the financial threat of mass tort litigation, more than regulation, drove the asbestos and tobacco industries to internal reform and product withdrawal. If the engineered‑stone industry is granted the same liability protection extended to firearms manufacturers, the analogous reform mechanism will be unavailable.

File 07 · Forward LookLuxury Vinyl Plank · the next category
07

The Next Material

Different chemistry. Same structural conditions. A consumer product growing at 13% annually with effectively no health surveillance on the workers producing or installing it.

Luxury Vinyl Plank flooring (LVP) — and its rigid‑core SPC and foam‑core WPC variants — is the fastest‑growing flooring category in the United States, with a 13.4% projected annual growth rate and a global market value of $33 billion in 2026. It is installed in roughly one in three U.S. kitchens and bathrooms in new construction and remodels, marketed as the affordable, waterproof, scratch‑resistant alternative to hardwood. It is also a PVC‑based product whose full lifecycle — from monomer production through installation off‑gas to landfill or incineration disposal — carries documented health and environmental concerns that have, to date, attracted virtually no public surveillance.

This investigation does not assert that LVP causes a specific occupational disease comparable to engineered‑stone silicosis. It asserts that the structural conditions that produced the silicosis crisis are present here: an aggressively‑marketed consumer product, a vulnerable workforce installing it at scale, a fragmented regulatory landscape that depends on the consumer to identify product‑specific hazards from voluntary certifications, and an industry that has not pre‑emptively conducted long‑term worker‑exposure studies. The same pattern, applied to a different chemistry.

Base PolymerPolyvinyl Chloride (PVC) · produced from vinyl chloride monomer (VCM)
VCM ClassificationIARC Group 1 carcinogen · liver angiosarcoma, hepatocellular carcinoma
Historical PlasticizerDEHP phthalate · 20–40% by mass · endocrine disruptor · largely phased out by 2020
Current PlasticizerDOTP (Dioctyl Terephthalate) · less safety data · evidence suggests estrogenic activity
EVA Foam BackingSome products still use phthalates in backing layer
Heavy MetalsTrace lead, cadmium documented in lower‑tier imports · Prop 65 warnings common
End‑of‑LifeNot biodegradable · incineration releases dioxins · landfill persistence: centuries
Microplastic SheddingWear surface degrades over lifecycle · emerging concern, limited research
Import ConcentrationChina, Vietnam, South Korea · weaker quality‑control surveillance than domestic
Worker SurveillanceNone at meaningful scale · installer exposure to glues, cutting dust, off‑gas not systematically tracked

The seven categories of concern, in declining specificity:

CAT 01
VCM production exposure. PVC manufacture concentrates VCM exposure in factory workers — overwhelmingly in countries (China, Vietnam) with weaker occupational health regimes than the U.S.
CAT 02
Installation glue and cutting exposure. LVP installers cut planks on site, often with electric saws producing dust whose composition includes PVC particles and plasticizer residues. No systematic surveillance data exists.
CAT 03
Indoor air quality post‑install. Off‑gassing of plasticizers and residual VOCs from new flooring measurable for 30–60 days post‑install. Severity dependent on product certification (FloorScore, GreenGuard Gold) — which is voluntary.
CAT 04
DOTP endocrine disruption signal. The replacement plasticizer for DEHP carries less safety data and emerging evidence of estrogenic activity. Long‑term in‑home exposure studies are absent.
CAT 05
Microplastic shedding. The wear layer abrades over the product's lifecycle. Resulting indoor microplastic load is documented but unquantified at scale.
CAT 06
Heavy metal contamination. Imported LVP (the majority of the U.S. market) periodically tests positive for trace lead and cadmium. California Prop 65 warnings remain common.
CAT 07
End‑of‑life disposal. The category is fundamentally not recyclable at scale. Incineration releases dioxins; landfill persistence is multi‑century. The waste stream from current installations will outlast the homes they are installed in.
"PVC is made with large quantities of toxic organochlorines such as dioxins and phthalates and releases them into indoor and outdoor environments. Both of these chemicals are bio‑accumulative and toxic to humans and all life." — Green Building Supply, on its policy of refusing to sell vinyl flooring (2026 update)

The parallel to engineered stone is not in the specific disease — silicosis is an acute, identifiable, terminal occupational illness, and there is no equivalent acute disease established for LVP. The parallel is in the structure of the market. A product enthusiastically promoted to consumers, installed at scale by a workforce with limited bargaining power and limited health surveillance, manufactured under regulatory regimes weaker than the U.S. baseline, with end‑of‑life and indoor‑air consequences that will manifest over decades rather than years. The U.S. asbestos response taught the industry that delay favours the manufacturer. The LVP category is structured to maximise that delay.

Recommendation · Active Surveillance Required

Alethea Solutions calls for: (1) mandatory FloorScore or GreenGuard Gold certification on all LVP sold for residential installation; (2) federal study of installer exposure to PVC cutting dust and glue off‑gas; (3) phase‑out of DOTP in favour of bio‑based plasticizers with full toxicity profiles; (4) end‑of‑life recovery program funded by manufacturer levy; and (5) public‑facing reporting on heavy‑metal content in imported product. None of these measures are currently in place. All are achievable without restricting consumer access to the category.

File 08 · ActionRequired interventions · regulatory · consumer · industry
08

What Should Happen

The interventions that would close the engineered‑stone crisis and prevent the LVP analogue. None of them require new science.

Alethea Solutions takes the position that the following measures are supported by the current evidence, are technically achievable without restricting consumer access to premium surface materials, and are politically achievable in a sequence that protects the manufacturers' legitimate commercial interests while ending the worker harm. They are organized in descending urgency:

01 · URGENT
California Cal/OSHA Standards Board should approve the May 21, 2026 petition to advance the engineered‑stone ban to formal rulemaking. The evidence threshold has been met. Delay produces additional silicosis cases that will not retroactively recover.
02 · URGENT
Congress should reject the Protection of Lawful Commerce in Stone Slab Products Act. Granting manufacturer immunity removes the financial accountability mechanism that historically drove industry reform. The bill should not advance from committee.
03 · NEAR‑TERM
Federal silicosis surveillance program. A national chest‑radiograph surveillance system equivalent to the federal Coal Mine Health and Safety Act program for black lung. Current OSHA regulations do not require B‑Reader results to be reported to public health authorities. This gap should be closed.
04 · NEAR‑TERM
Other states should replicate California's STOP Act framework. Texas, Florida, Arizona, and Illinois are the next likely hot spots given fabrication workforce concentration. None has yet adopted equivalent legislation.
05 · NEAR‑TERM
Industry transition to low‑silica and silica‑free engineered stone. The Australian market transitioned within months. The same alternatives exist for the U.S. market. The transition can be accelerated by California's ban without requiring federal action.
06 · MEDIUM‑TERM
Mandatory installer health surveillance for LVP, laminate, and other PVC‑adjacent flooring categories. The current absence of any baseline data on installer exposure is a regulatory gap that will produce future harm if not closed.
07 · MEDIUM‑TERM
End‑of‑life recovery program for LVP. The category is non‑recyclable as currently formulated. A manufacturer‑funded levy supporting takeback and processing is the same model used for paint, electronics, and tires.
08 · LONG‑TERM
Standardised consumer disclosure for indoor‑air‑contact materials. FloorScore and GreenGuard certifications are voluntary. A federal floor — comparable to Energy Star or California Air Resources Board CARB Phase 2 — would close the disclosure gap that currently shifts the diligence burden to the consumer.

None of the above interventions require a scientific advance. All are achievable with existing tools, existing precedent, and existing regulatory architecture. The barrier is political, not technical. The cost of inaction is being absorbed, in real time, by a workforce that has the least capacity to absorb it.

"The fabrication of high‑silica engineered stone poses unacceptable risk even with controls in place. The product itself is the hazard. Australia reached this conclusion in 2024. California is now positioned to reach the same conclusion. The United States, at the federal level, has not yet been willing to." — Summary finding, this investigation
An investigation is only as honest as its sources.

Primary Reporting

Public Health Watch — California silicosis epidemic coverage (2024–2026) · KQED — "California Steps Closer to Ban on Engineered Stone" (May 2026) · CBS News — "Silicosis, lung disease once linked to mining, hits workers in countertops industry" (March 2026) · NPR — "Kitchen countertop workers are dying" (Jan 2026) · In These Times — "After Decades of Quiet Rumbling" (April 2026) · The American Prospect — "My Lungs Had Nothing Left" (March 2026) · Bloomberg Law — "Next Black Lung: Countertop Silica Dust Cases Pile Up in Courts" (April 2026) · IOSH Magazine — "Silicosis and engineered stone: the next asbestosis?" (June 2025) · Los Angeles Today — "California Tackles Silicosis Epidemic" (March 2026)

Scientific & Regulatory

NIOSH B Reader Program · OSHA 29 CFR 1910.1053 (Respirable Crystalline Silica standard) · ILO International Classification of Radiographs of Pneumoconioses · Safe Work Australia 2023–2024 engineered stone review · Western Occupational & Environmental Medical Association petition (Dec 2025) · ACS Chemical Research in Toxicology (Combined Role of Silanols and Oxidative Stress in Determining Engineered Stone Dust Toxicity, 2025) · PMC — Active Surveillance of Engineered Stone Workers (2024) · California STOP Act (SB‑20, Oct 2025) · Cal/OSHA Standards Board petition documents · California Department of Public Health silicosis registry · IARC Monograph (Crystalline silica · Group 1 carcinogen) · IARC Monograph (Vinyl chloride monomer · Group 1 carcinogen)

Methodology & Disclosure

This report combines primary reporting from named sources above with regulatory documents and peer‑reviewed scientific literature. Case counts reflect California Department of Public Health and Cal/OSHA figures as of April 8, 2026. Projections of future disease incidence are drawn from California Department of Public Health modeling. Direct quotations are attributed to their original publication. Where sources conflicted, the more recent and the more methodologically rigorous source prevailed. Alethea Solutions has no financial relationship with any manufacturer or fabricator named in this report. This investigation is offered in the public interest under the Alethea editorial standard: disclosure, verification, public interest.

Lead Investigator: Marc A. Reynolds · © 2026 · Field Report 01
← Back to CDG Digital Media
Share privately Email Text